Baillie Gifford & Co’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-385
| Closed | -$4.55K | – | 464 |
|
|
2022
Q4 | $4.55K | Hold |
385
| – | – | ﹤0.01% | 453 |
|
|
2022
Q3 | $8K | Hold |
385
| – | – | ﹤0.01% | 423 |
|
|
2022
Q2 | $12K | Hold |
385
| – | – | ﹤0.01% | 393 |
|
|
2022
Q1 | $16K | Hold |
385
| – | – | ﹤0.01% | 390 |
|
|
2021
Q4 | $17K | Hold |
385
| – | – | ﹤0.01% | 397 |
|
|
2021
Q3 | $19K | Sell |
385
-38
| -9% | -$1.88K | ﹤0.01% | 377 |
|
|
2021
Q2 | $27K | Hold |
423
| – | – | ﹤0.01% | 328 |
|
|
2021
Q1 | $39K | Buy |
423
+16
| +4% | +$1.48K | ﹤0.01% | 292 |
|
|
2020
Q4 | $36K | Buy |
+407
| New | +$36K | ﹤0.01% | 284 |
|